https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2010-12-06 / Clin. Cancer Res. 2011 Mar;17(6):1603-15
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2010-12-06 / Clin. Cancer Res. 2011 Mar;17(6):1603-152010-12-06 00:00:002019-02-15 08:46:43Gene expression profile correlates with T-cell infiltration and relative survival in glioblastoma patients vaccinated with dendritic cell immunotherapy
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2010-04-01 / Pediatr Blood Cancer 2010 Apr;54(4):519-25
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2010-04-01 / Pediatr Blood Cancer 2010 Apr;54(4):519-252010-04-01 00:00:002021-11-15 14:45:11Adjuvant dendritic cell-based tumour vaccination for children with malignant brain tumours
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2010-04-01 / Expert Rev Neurother 2010 Apr;10(4):483-6
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2010-04-01 / Expert Rev Neurother 2010 Apr;10(4):483-62010-04-01 00:00:002019-02-15 08:46:44Dendritic cell vaccines to combat glioblastoma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2010-01-01 / Neurosurg. Clin. N. Am. 2010 Jan;21(1):139-57
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2010-01-01 / Neurosurg. Clin. N. Am. 2010 Jan;21(1):139-572010-01-01 00:00:002019-02-15 08:46:45Dendritic cell vaccines for brain tumors
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2010-01-01 / Neurosurg. Clin. N. Am. 2010 Jan;21(1):195-9
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2010-01-01 / Neurosurg. Clin. N. Am. 2010 Jan;21(1):195-92010-01-01 00:00:002019-02-15 08:59:37Monitoring immune responses after glioma vaccine immunotherapy
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2010-01-01 / Neurosurg. Clin. N. Am. 2010 Jan;21(1):111-23
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2010-01-01 / Neurosurg. Clin. N. Am. 2010 Jan;21(1):111-232010-01-01 00:00:002019-02-15 08:48:31Heat shock proteins in glioblastomas
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2010-01-01 / Neurosurg. Clin. N. Am. 2010 Jan;21(1):95-109
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2010-01-01 / Neurosurg. Clin. N. Am. 2010 Jan;21(1):95-1092010-01-01 00:00:002019-02-15 08:47:25Clinical applications of a peptide-based vaccine for glioblastoma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2009-12-24 / J. Neurooncol. 2010 Jul;98(3):395-405
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2009-12-24 / J. Neurooncol. 2010 Jul;98(3):395-4052009-12-24 00:00:002009-12-24 00:00:00Transcranial electro-hyperthermia combined with alkylating chemotherapy in patients with relapsed high-grade gliomas: phase I clinical results
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2009-11-01 / Expert Rev Anticancer Ther 2009 Nov;9(11):1577-82
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2009-11-01 / Expert Rev Anticancer Ther 2009 Nov;9(11):1577-822009-11-01 00:00:002019-02-15 08:48:32Heat-shock protein vaccines as active immunotherapy against human gliomas
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2009-10-27 / J. Immunol. Methods 2010 Jan;352(1-2):169-73
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2009-10-27 / J. Immunol. Methods 2010 Jan;352(1-2):169-732009-10-27 00:00:002021-11-15 14:45:35Technical advancement in regulatory T cell isolation and characterization using CD127 expression in patients with malignant glioma treated with autologous dendritic cell vaccination
